Latest filing published 19 Feb 2021 for Cellular Biomedicine Group, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tony Liu: trading record in brief
Tony Liu appears in our data through filings on Cellular Biomedicine Group, Inc. shares, published by SEC (Form 4). The record holds 16 filings, for trades running from 16 April 2013 to 19 February 2021.
The open-market record is one-sided, with 11 purchases worth €725k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants.
In size, the median ticket on the buying side is €7,282. On 1 out of 9 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
On 19 February 2021 came the latest disclosure, a share grant in Cellular Biomedicine Group, Inc. The clock since the last published purchase (27 December 2017) now reads 3,239 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tony Liu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 240,000 shares0Common StockSEC:0001654954-21-001898:0
- 476,817 sharesCommon StockSEC:0001654954-21-001898:1
- 10,700 sharesCommon StockSEC:0001654954-21-001898:2
- 29,167 shares@ US$12.0080.6% of flowCommon StockSEC:0001654954-17-011879:0Canonical exit: 22 Mar 2018 (T+90)
- 800 shares@ US$6.811.3% of flowCommon StockSEC:0001654954-17-005408:0Canonical exit: 4 Sept 2017 (T+90)
- 100 shares@ US$6.780.2% of flowCommon StockSEC:0001654954-17-005408:1Canonical exit: 4 Sept 2017 (T+90)
- 2,000 shares@ US$6.833.3% of flowCommon StockSEC:0001654954-17-005408:2Canonical exit: 4 Sept 2017 (T+90)
- 2,100 shares@ US$6.843.5% of flowCommon StockSEC:0001654954-17-005408:3Canonical exit: 4 Sept 2017 (T+90)
- 100 shares@ US$6.850.2% of flowCommon StockSEC:0001654954-17-005408:4Canonical exit: 4 Sept 2017 (T+90)
- 1,200 shares@ US$6.842.0% of flowCommon StockSEC:0001654954-17-005408:6Canonical exit: 4 Sept 2017 (T+90)
- 2,900 shares@ US$6.854.8% of flowCommon StockSEC:0001654954-17-005408:7Canonical exit: 4 Sept 2017 (T+90)
- 800 shares@ US$6.801.3% of flowCommon StockSEC:0001654954-17-005408:5Canonical exit: 4 Sept 2017 (T+90)
- 975 shares@ US$11.402.8% of flowCommon StockSEC:0001654954-17-003027:1
- 120,000 shares0Common StockSEC:0001654954-17-003027:0
- 100,000 shares@ US$5.00Common Stock, par value $0.001 per shareSEC:0001354488-14-003027:0Canonical exit: 20 Aug 2014 (T+90)
- 700 shares@ US$5.00Common StockSEC:0001569983-13-000002:0Canonical exit: 15 Jul 2013 (T+90)
16 of 16 declarations